Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian La

Showing results (71-80 of 280) with videos related to

Pageof 28
Sort By:
Cancers|February 10, 2024
How [<sup>18</sup>F]FDG-PET/CT Affects the Management of Patients with Differentiated Thyroid Carcinoma in Clinical RoutinesJonas Vogel, Julia Sekler, Brigitte Gückel, et al.
Nature Reviews. Cancer|May 31, 2023
Advances in PET imaging of cancerJohannes Schwenck, Dominik Sonanini, Jonathan M Cotton, et al.
Diagnostics (Basel, Switzerland)|June 10, 2023
Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI StudyChristian Philipp Reinert, Cecilia Liang, Matthias Weissinger, et al.
Biomed Research International|February 14, 2018
Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer PatientsFrancesco Fiz, Samine Sahbai, Cristina Campi, et al.
Hellenic Journal of Nuclear Medicine|March 2, 2016
Towards tracer dose reduction in PET studies: Simulation of dose reduction by retrospective randomized undersampling of list-mode dataSergios Gatidis, Christian Würslin, Ferdinand Seith, et al.
Neuroimage. Clinical|July 14, 2016
Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patientsAngela Deutschländer, Christian la Fougère, Kai Boetzel, et al.
Psychiatry Research|August 18, 2009
Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECTGisela Johanna Elisabeth Schmitt, Eva Maria Meisenzahl, Thomas Frodl, et al.
Frontiers in Human Neuroscience|May 6, 2016
Differing Patterns of Altered Slow-5 Oscillations in Healthy Aging and Ischemic StrokeChristian La, Pouria Mossahebi, Veena A Nair, et al.
Plos One|June 1, 2017
SUV-quantification of physiological lung tissue in an integrated PET/MR-system: Impact of lung density and bone tissueFerdinand Seith, Holger Schmidt, Sergios Gatidis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2017
18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy startFerdinand Seith, Andrea Forschner, Holger Schmidt, et al.
Pageof 28

Showing results (71-80 of 280) with videos related to

Sort By:
Pageof 28
Cancers|February 10, 2024
How [<sup>18</sup>F]FDG-PET/CT Affects the Management of Patients with Differentiated Thyroid Carcinoma in Clinical RoutinesJonas Vogel, Julia Sekler, Brigitte Gückel, et al.
Nature Reviews. Cancer|May 31, 2023
Advances in PET imaging of cancerJohannes Schwenck, Dominik Sonanini, Jonathan M Cotton, et al.
Diagnostics (Basel, Switzerland)|June 10, 2023
Whole-Body Magnetic Resonance Imaging (MRI) for Staging Melanoma Patients in Direct Comparison to Computed Tomography (CT): Results from a Prospective Positron Emission Tomography (PET)/CT and PET/MRI StudyChristian Philipp Reinert, Cecilia Liang, Matthias Weissinger, et al.
Biomed Research International|February 14, 2018
Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer PatientsFrancesco Fiz, Samine Sahbai, Cristina Campi, et al.
Hellenic Journal of Nuclear Medicine|March 2, 2016
Towards tracer dose reduction in PET studies: Simulation of dose reduction by retrospective randomized undersampling of list-mode dataSergios Gatidis, Christian Würslin, Ferdinand Seith, et al.
Neuroimage. Clinical|July 14, 2016
Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patientsAngela Deutschländer, Christian la Fougère, Kai Boetzel, et al.
Psychiatry Research|August 18, 2009
Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECTGisela Johanna Elisabeth Schmitt, Eva Maria Meisenzahl, Thomas Frodl, et al.
Frontiers in Human Neuroscience|May 6, 2016
Differing Patterns of Altered Slow-5 Oscillations in Healthy Aging and Ischemic StrokeChristian La, Pouria Mossahebi, Veena A Nair, et al.
Plos One|June 1, 2017
SUV-quantification of physiological lung tissue in an integrated PET/MR-system: Impact of lung density and bone tissueFerdinand Seith, Holger Schmidt, Sergios Gatidis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2017
18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy startFerdinand Seith, Andrea Forschner, Holger Schmidt, et al.
Pageof 28